Mounjaro:
Weight Loss Treatment
- GLP-1 injection taken once a week
- MHRA approved for weight loss
- Up to 22% of weight loss
Treatment plan starts from
Appetite Suppression
Healthy Weight Loss
Improves Blood Sugar Control
What is Mounjaro?
It is a ground breaking treatment for weight management. This injectable weight loss medication uses a dual-action advantage, targeting two key gut hormones (GLP-1 and GIP) to achieve significant weight loss. Clinical studies have shown participants achieved impressive results, losing up to 22% of their body weight within a year.*
What makes Mounjaro unique:
Long-lasting Energy: It helps regulate food release, keeping you energised throughout the day.
With GLP-1 Medication
Diet & Exercise alone
How does Mounjaro work?
Mounjaro (tirzepatide) exerts its effects through a dual-incretin receptor agonist mechanism. It works with two key incretin hormones in the gut which are involved in glycemic control and appetite regulation.
Mounjaro’s dual action on GLP-1 and GIP receptors influences various organs, leading to weight loss and improved weight management.
Brain
GLP-1 Activity
Reduces food intake
May reduce food intake
Systemic effects
GIP AND GLP-1 Activity
Increases insulin sensitivity
Stomach
GLP-1 Activity
Slows passing of food through the stomach
Pancreas
GIP Activity
Increases insulin
Increases glucagon
Increases insulin
Reduces glucagon
Brain
GLP-1 Activity
Reduces food intake
May reduce food intake
Systemic effects
GIP AND GLP-1 Activity
Increases insulin sensitivity
Stomach
GLP-1 Activity
Slows passing of food through the stomach
Pancreas
GIP Activity
Increases insulin
Increases glucagon
Increases insulin
Reduces glucagon
Mounjaro: A Promising New Player
The SURMOUNT program demonstrated significant weight loss in participants using Mounjaro alongside lifestyle modifications.
People taking Mounjaro lost up to
22%
of body weight
Continued
Weight loss over
72
Weeks
TESTIMONIALS
Real Stories, Real Results:
Hear from Our Satisfied Customers
-
Damian Thorn, 32I was skeptical at first, but Priman's treatment plan exceeded my expectations. Not only did I see significant results, but the support and guidance from their team made the journey enjoyable and sustainable. Highly recommend
-
Jack Sparrow, 44Priman's approach to wellness truly changed my life. I feel more energetic, confident, and in control of my health than ever before. Thank you for providing such effective and personalised solutions
-
Jack Sparrow, 44Priman's approach to wellness truly changed my life. I feel more energetic, confident, and in control of my health than ever before. Thank you for providing such effective and personalised solutions
Embarking on the Journey
to Healthier Living
FAQ
Your Mounjaro Questions Answered: Explore our FAQ section
Yes, it is available in the UK and was approved for weight loss in November 2023 under specific criteria set by National Institute for Health and Care Excellence (NICE). To buy Mounjaro get assessed by a healthcare professional to see if Mounjarois right for you. If you meet the criteria, your doctor will provide you with a prescription to buy Mounjaro.
Mounjaro comes in different strengths to suit individual needs. As with most medications, the cost can vary depending on the dosage prescribed by your doctor. We at Priman is committed to offering Mounjaro at competitive rates to help you achieve your weight loss goals.
- Digestive Issues: These are the most frequent side effects and can include nausea, vomiting, diarrhea, constipation, indigestion, stomach pain, and decreased appetite.
- Injection Site Reactions: You might experience some redness, swelling, or itching where you injected the medication.
No, Mounjaro and Ozempic are not exactly the same medication, although they share some similarities. Both Mounjaro and Ozempic belong to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, also known as incretin mimetics. The key differences between both these medication are:
- Mechanism: Mounjaro has a dual action, targeting both GLP-1 and GIP receptors. Ozempic works only on GLP-1 receptors.
- Effectiveness: Studies suggest Mounjaro may be more effective for blood sugar control and weight loss.
Yes, you can buy Mounjaro online in the UK, but it requires a prescription. You’ll need to consult with a licensed healthcare provider who can assess your eligibility based on NICE criteria. This consultation can be done entirely online. If approved, your provider can create a treatment plan that may include a Mounjaro prescription.
Important to note: Mounjaro is not available for purchase over-the-counter, as other weight loss injections and weight loss tablets.
While nausea, diarrhea, and decreased appetite are common side effects of Mounjaro, body aches haven’t been reported in clinical trials. This suggests no current evidence directly links Mounjaro to muscle or joint pain. However, if you experience body aches after starting Mounjaro, it’s important to discuss this with your healthcare professional.
No, Mounjaro is not an insulin.
Mounjaro is an injectable weight loss medication that uses a dual-action advantage, targeting two key gut hormones (GLP-1 and GIP) to achieve aid in weight loss.
Mounjaro begins to work quickly. You may see its initial impact on your blood sugar levels within the first 4 weeks. However, achieving the full benefits of Mounjaro can take time. It typically takes about 4 to 6 months of consistent use to experience its maximum effectiveness.
Few key things to consider before using Mounjaro:
Medical History:
- Pre-existing conditions: Mounjaro may not be suitable if you have certain health problems like severe digestive issues (gastroparesis), a history of pancreatitis, or uncontrolled type 1 diabetes.
- Allergic reactions: If you’ve had an allergic reaction to Mounjaro or its ingredients in the past, it won’t be recommended.
- Medications: Tell your doctor about all medications you’re taking, including prescription drugs, over-the-counter supplements, and herbal remedies. Mounjaro can interact with certain medications.
Potential Side Effects:
- Digestive issues: Nausea, vomiting, diarrhea, and constipation are common side effects of Mounjaro, though they usually lessen over time .
- Other considerations: Mounjaro can elevate your risk of dehydration, gallbladder problems, and low blood sugar (hypoglycemia). Be aware of these potential side effects and discuss them with your doctor.
Additionally:
- Pregnancy and breastfeeding: Mounjaro is not recommended for pregnant or breastfeeding women.
Before starting Mounjaro, a thorough assessment with your healthcare professional is crucial to determine if it’s the right choice for you.
Mounjaro comes in pre-filled pens offering various dosage options: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per dose. Typically, treatment begins with the lowest dose and may gradually increase over time, as directed by your healthcare professional.
The best place to store Mounjaro is in the fridge. But you can keep it at room temperature, if needed, for up to 21 days. Either way, make sure Mounjaro stays in its original box until you’re ready to use it. Store it in the fridge until you’re ready to inject your dose. The ideal temperature range for storage is 36°F to 46°F.
While there’s no direct interaction between the two, it’s best to avoid or limit alcohol when taking Mounjaro. Alcohol can potentially worsen this injection’s digestive side effects, such as nausea and vomiting.
Mounjaro Overdose: Seek Help Immediately
It is a powerful medication, and exceeding the prescribed dosage can be dangerous. If you think you or someone you know has accidentally used too much Mounjaro, talk to your healthcare professional immediately. Too much of the medicine may cause low blood sugar (hypoglycaemia) and can make you feel sick.
*Lapid, N. (ed.) (2023) More weight loss with Mounjaro than ozempic: Data analysis, Medscape.
*Samms, R. J., Coghlan, M. P. and Sloop, K. W. (2020) “How may GIP enhance the therapeutic efficacy of GLP-1?,” Trends in endocrinology and metabolism: TEM, 31(6), pp. 410–421. doi: 10.1016/j.tem.2020.02.006.
*Jastreboff, A. M. et al. (2022) “Tirzepatide once weekly for the treatment of obesity,” The New England journal of medicine, 387(3), pp. 205–216. doi: 10.1056/nejmoa2206038.
*Wadden, T. A. et al. (2023) “Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial,” Nature medicine, 29(11), pp. 2909–2918. doi: 10.1038/s41591-023-02597-w.
*Lilly.com. Available at: https://www.lilly.com/news/media/media-kits/mounjaro